Inmedix utilizes cloud-based clinical diagnostics and medical-grade heart rate variability (HRV) analysis to enhance the precision of autoimmune disease management. The platform aims to improve patient outcomes by providing actionable insights derived from advanced immuno-autonomics research.
Funding
$13.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Managing autoimmune diseases is challenging due to their complexity and variability, often leading to imprecise diagnoses and ineffective treatment plans. Traditional diagnostic methods may lack the sensitivity to detect subtle changes in the autonomic nervous system, which plays a crucial role in immune regulation. This can result in delayed or inappropriate interventions, impacting patient outcomes and quality of life.
Solution
Inmedix offers a cloud-based platform that leverages medical-grade heart rate variability (HRV) analysis to provide clinicians with enhanced insights into the autonomic nervous system's influence on immune function. By applying advanced immuno-autonomics research, the platform aims to improve the precision of autoimmune disease management. The platform analyzes HRV data to identify patterns and biomarkers associated with specific autoimmune conditions, enabling more targeted and personalized treatment strategies. This approach facilitates earlier detection of disease activity, better monitoring of treatment response, and ultimately, improved patient outcomes.
Target Audience
The primary users are clinicians specializing in autoimmune diseases, including rheumatologists, immunologists, and general practitioners managing patients with autoimmune conditions.
Features
- Cloud-based platform for secure data storage and accessibility
- Medical-grade HRV analysis algorithms for accurate autonomic nervous system assessment
- Integration of immuno-autonomics research to identify disease-specific biomarkers
- Generation of actionable insights to guide treatment decisions